ACAD

Acadia Pharmaceuticals Inc.

Health Care
42
/100
SELL
Signal 2.0 composite score — 7-pillar quant rating updated daily.

Signal 2.0

7-Pillar Score Breakdown

Each pillar scores 0–100. The composite is a regime-weighted blend of all seven.

Fundamentals & Quality
53
Valuation
17
Technicals & Momentum
29
Sentiment & News
60
Earnings Quality
9
Risk Profile
42
Market Regime
70

Premium Insights

Deeper Analysis — Unlocking Soon

Advanced institutional-grade signals are coming to Quantex Premium. Join the waitlist for early access.

Institutional Flow Signal ★ PREMIUM
🔒 PREMIUM Unlock with Premium
Earnings Risk Score ★ PREMIUM
73
Risk Score / 100
MODERATE
EPS Beat Est.
Report in ~14 days
🔒 PREMIUM Unlock with Premium

Fundamentals

Key Metrics

Sourced from the daily universe scan. Open the terminal for the full financial deep-dive.

Market Cap
$3.4B
P/E Ratio
8.8x
Revenue Growth
+21.9%
EPS Growth
+13.3%
Profit Margin
33.4%
Beta
0.89

See the full picture for ACAD.

Run live Signal 2.0 scoring, deep financial statements, DCF valuation, CAPM, and options pricing — free, no account required.

Open Full Analysis → Browse All Stocks